Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Lundbeck Canada Inc. v. Novopharm Limited and the Minister of Health/Ratiopharm Inc. and the Minister of Health/Pharmascience Inc. and the Minister of Health/Sandoz Canada Inc. and the Minister of Health- escitalopram NOC proceedings

Fasken
Reading Time 1 minute read

Overview

Proceedings to prohibit the Minister of Health from issuing a notice of compliance which would allow the sale of generic versions of escitalopram, a drug used in the treatment of depression, until the expiry of Canadian patent no 1,339,452. The cases were stayed pending the resolution of the Genpharm, Apotex and Cobalt matters. The notices of allegation were eventually withdrawn. Lundbeck was advised in these proceedings by a team from Fasken Martineau that included Marie Lafleur, Julie Desrosiers and Christian Leblanc.

Team